Fast orodispersible tablets of Naratriptan Hydrochloride

ORIGINAL ARTICLE
Formulation development and optimization of fast orodispersible tablets of
naratriptan hydrochloride by using factorial design
N.A. Oza1*, A.R. Sahu1, S.N. Tripathi2, P.U. Patel3, L.D. Patel4, A. Ramkishan5
1
Assistant Professor, 2PG Student, 4Director and Professor, C.U. Shah College of Pharmacy and Research, Wadhwancity, Surendranagar.
3
Professor and Head, S.K. Patel College of Pharmaceutical Education and Research, Kherva, Gujarat.
5
Depyuty Drug Controller, Central Drug Standard Control Organization, New Delhi.

ABSTRACT
BACKGROUND: The present research was to develop oral fast disintegrating tablets of naratriptan hydrochloride.
MATERIALS AND METHODS: Tablets containing naratriptan hydrochloride, sodium starch glycolate (SSG),
croscarmellose sodium (CCS) and kyron-T314 were prepared by direct compression technique. Among three super
disintegrating agents, croscarmellose sodium was found to have better fast disintegrating properties and higher
dissolution efficiency. A 32 full factorial design was employed to investigate the influence of two formulation
variables: amount of croscarmellose sodium and kyron-T314. The tablets were evaluated for friability and
disintegration time. RESULTS: The results of multiple linear regression analysis revealed that for obtaining a
rapidly disintegrating dosage form, tablets should be prepared using an optimum ratio of croscarmellose sodium and
kyron-T314. Contour plots were also presented to graphically represent the effect of the independent variables on
the disintegration time and percent friability. CONCLUSION: A checkpoint batch was prepared to prove that
validity of the evolved mathematical model. There was no difference observed in release profile and drug content
after accelerated stability study for 1 month.
Keywords: Contour plot, Croscarmellose sodium, Factorial design, Naratriptan Hydrochloride tablets,
Orodispersible tablets

INTRODUCTION
Oral route of drug administration is the most
appealing route for the drug delivery. Among the
various dosage forms tablet is one of the most
preferred dosage form because of its ease of
manufacturing, convenience in administration,
accurate dosing, stability compared with other forms
etc. The bioavailability of a drug is dependent on
disintegration, dissolution, and various physiological
factors. In the recent yrs, scientists have focused
their attention on the formulation of quickly
disintegrating tablets and orodispersible tablets
(ODTs). Food and Drug Administration of United
States defined ODT as: “A solid dosage form
containing medicinal substance or active ingredient
which disintegrates rapidly usually within a second
when placed upon the tongue”. The disintegration
time for ODTs generally ranges from several
seconds to about a minute1,2. Orally disintegrating
tablets are formulated by employing many processes,
which differ in their methodology and the ODTs
may vary in various properties such as, mechanical
strength of tablets, taste and mouth feel, swallow
ability, drug dissolution in saliva, bioavailability and
stability. The task of developing rapidly
disintegrating tablets is accomplished by using a
suitable diluent and superdisintegrant.
*Corresponding Author
Mr. Nishant A. Oza (Assistant Professor)
Department of Pharmaceutics,
C.U. Shah College of Pharmacy and Research,
Wadhwancity, Surendranagar (Gujarat-India)
Email: ozanishant@gmail.com
Naratriptan hydrochloride is approved for acute oral
migraine therapy. The drug is a selective agonist of
5-hydroxytryptamine1 (5-HT1) receptors, so it used
in treatment of migraine attack and as well as in
nausea, vomiting and headache. Naratriptan
hydrochloride half life is 5 to 6 hrs. Hence, it is most
suitable for manufacture of ODT because of its
longer half life. In the Phase III trials of naratriptan
hydrochloride compared with placebo, the relief at
four hours was obtained in 60% and 68% of patients
using the 2.5 mg dose, with recurrence of headache
in 24 hours in 27% and 28% of patients3,4,5. The aim
of present study was to develop fast disintegrating
tablet of naratriptan with possible advantages like,
quick onset of action due to rapid dissolution and
enhanced rapid absorption. Sodium starch glycolate
(SSG), croscarmellose sodium (CCS) and kyron-
T314 were screened in the present study, and the
best one was used for further studies. Another
approach used in developing ODT was to maximize
the pore structure of the tablets. The direct
compression technique was adopted for formulating
the ODT of naratriptan hydrochloride. A 32 full
factorial design was applied in optimization of the
oral disintegrating tablets of naratriptan
hydrochloride. The concentration of
superdisintegrants CCS or kyron-T314 was taken as
an independent variable. The dependent variables
were friability and disintegration time to find out the

48 Int J Res Med. 2013; 2(4);48-53 e ISSN:2320-2742 p ISSN: 2320-2734

 Fast orodispersible tablets of Naratriptan Hydrochloride

effect of independent variables on dependent test was performed using a dissolution test apparatus
variables6,7. (USP TDT 06 PL, Electrolab, Mumbai) with a
MATERIALS AND METHODS paddle rotation at 50 rpm. After placing a tablet
Materials: Naratriptan hydrochloride, sodium starch containing 2.5 mg of naratriptan in 6.8 pH buffer
glycolate (SSG), croscarmellose sodium (CCS), solution, the 5 ml solution was withdrawn and
polacrellin potassium (kyron-T314), talc, citric acid, filtered through a watmen filter of 0.2 mm pore size
mannitol, avicell pH 102, manitol megnesium at different intervals of 1, 2, 3, 4, 6, 8, 10, 20, 30 min
stearet, sodium steryfumret were obtained as and diluted suitably using 6.8 pH buffer solution and
generous gift from West Coast Pharmaceuticals Ltd., analyzed at 224 nm for cumulative drug release
Ahmedabad, Gujarat. (India). List of Equipments: using (UV-2450, Shimadzu Corp., Japan) spectro
Digital weighing balance (Contact Equipments Pvt. photometer13. Accelerated Stability Study: Stability
Ltd), UV Spectrophotometer {UV (USP)–1700, M/s study of batch F5 was carried out at 400C in a
Shimadzu}, Dissolution test apparatus (Electrolab- humidity chamber having 75% RH. Samples were
TDT-08L), FTIR apparatus (M/s Shimadzu), pH withdrawn at regular intervals during the study of 60
meter (Lab India), Tray Dryer (EIE-103, EIE days. Formulation is evaluated for change in in-vitro
Instrument Pvt. Ltd., Ahmedabad, India), Rotary drug release, hardness and disintegration time14,15,16.
Tablet Compression Machine LAB-Press 8 station; RESULTS
(Hardik Engineering Works, Ahmedabad, India.) Table 1: Formulation of batches T1 –T11 for
Hardness Tester (Monsanto Hardness Tester), Bulk Optimizing Super disintegrating agent
Density measuring apparatus (EIE-Instrument), Ingredie Batch
Stability Chamber (Thermo Lab), Roche Friabilator nts (mg) T1 T2 T3 T4 T5 T6 T7 T8 T9 T10 T11
(EIE- Instrument). Preparation of Orodispersible Naratrip
Tablets: Each ingredient was passed through #60 tan
2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5
mesh sieve separately. The drug and the diluents hydrchl
oride
were mixed in small portion and blended to get SSG 3 4.5 6 7.5 - - - - - - -
uniform mixture. The remaining ingredients were CCS - - - - 3 4.5 6 - - - -
weighed and mixed in geometrical order. The tablets Kyron
- - - - - - - 3 4.5 6 7.5
314
were prepared by direct compression technique8,9. Avicel
Optimization of Super Disintegrating Agent: Oral 90 90 90 90 90 90 90 90 90 90 90
PH102
fast disintegrating tablets were prepared by direct Manitol 45.5 44 43 41 45.5 44 42.5 45.5 44 42.5 42
compression. Croscamellose sodium, sodium starch SSF 2.25 2.25 2.25 2.25 2.25 2.25 2.25 2.25 2.25 2.25 2.25
Talc 3 3 3 3 3 3 3 3 3 3 3
glycolate and kyron-T314 were used in varying D.M
concentration as shown in Table-1. Batch (T1 to T4) 3 3 3 3 3 3 3 3 3 3 3
orange
contained 2, 3, 4 and 5% of sodium starch glycolate, Citric
1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5
acid
respectively. Batch (T5 to T7) contained 2, 3 and 4% Final
croscamellose sodium, respectively and batch (T8 to 150 150 150 150 150 150 150 150 150 150 150
weight
T11) contained 2,3,4, and 5% kyron-T314, Table 2: FTIR Drug-excipient compatibility data
respectively10,11. Drug Excipient Compatibility Individua Mixture
Drug / Function
Study: Drug- excipient interaction plays a vital role l Peak Peak Inference
Excipiets al group
( cm-1) (cm-1)
in the release of drug from formulation. Fourier 2⁰ Amine
Naratryptan
transform infrared spectroscopy (FTIR) has been 3450 3447 No Change
Hydrochloride R2-NH
used to study the physical and chemical interactions Sodium starch Carboxyl
1242 1247 No Change
glycolate Group
between drug and the excipients used. Fourier
Ether 1157 1153 No Change
transform infrared (FTIR) spectra of naratriptan Croscarmrllose
Methylene 1457 1458 No Change
sodium
hydrochloride, croscarmellose sodium, sodium Ether 1114 1108 No Change
starch glycolate, kyron-T 314, mannitol, and Methylene 1473 1472 No Change
Mannitol Hydroxyl
physical mixture of naratriptan hydrochloride were 1⁰-OH
1044 1041 No Change
recorded using KBr mixing method on FTIR Kyron-T314
Carbonyl
1557 1558 No Change
instrument 12. Spectrograph shown as in Figure 1 and Group
MCC Ether 1143 1140 No Change
2. Drug expcipient compatibility data were presented 2
Full Factorial Design: A 3 randomized full
in Table-2. Evaluation of Orodispersible
factorial design was adopted to optimize the
Tablets: The tablets were evaluated for various
variables. In the design, 2 factors were evaluated,
parameters like weight variation, thickness,
each at 3 levels, and experimental trials were
hardness, friability, wetting time, water absorption
performed at all 9 possible combinations. The
ratio, disintegration time ware measured as described
amount of superdiintegrating agent (croscarmellose
by Gohel M et al13, Swamy P A et al14 and Malke S
sodium, X1) and (kyron-T314, X2) were chosen as
et al15. In vitro Dissolution Test: In vitro dissolution
49 Int J Res Med. 2013; 2(4);48-53 e ISSN:2320-2742 p ISSN: 2320-2734
 Fast orodispersible tablets of Naratriptan Hydrochloride

independent variables in a statistical model Figure 1: FTIR spectrum of Naratriptan

incorporating interactive and polygonal terms were Hydrochloride
used to evaluate the responses. The disintegration
time (DT) and percent friability (%F) were
selected as depende nt variables. Batches of
factorial design were shown in Table-4.
Table 3: Result and Evaluation of Batch T1- T11
Water
Weight Fria Weting Thic
Form Hard Drug Absorp
varia bilit Tim kn D.T
ulatio nes content tion
tion y e ess (sec)
n Kg/cm2 % ratio
(mg) % (sec) (mm)
%
T1 148.7 3.5 0.81 95.17 59.02 83.70 2.98 62.9
Figure 2: FTIR Spectrum of Physical mixture
T2 148.7 3.1 0.64 97.58 56.08 87.70 2.97 59.9
T3 148.7 2.98 0.73 98.41 53.03 93.40 2.99 55.2
T4 148.8 2.97 0.63 98.27 51.05 94.50 3.1 58.3
T5 148.1 3.6 0.93 99.17 40.4 79.60 2.97 43.2
T6 148.9 3.2 0.62 101.5 37.8 83.60 2.96 41.1
T7 148.4 2.98 0.8 102.4 35.7 91.20 2.94 39.5
T8 148.7 3.5 0.73 94.17 55.5 79.80 2.93 59.3
T9 148.5 3.12 0.67 98.48 43.5 85.80 2.94 47.2
T10 148.9 2.98 0.74 101.4 40.25 89.30 2.97 45.3
T11 148.8 2.97 0.79 102.5 38.08 92.40 2.96 43.3
n=6 Figure 3: Cumulative % drug release of Batches
Table 4: Full Factorial Design Batches of Oral T3, T7 and T11
disintegrating Tablets
Variable Levels in
CPR vs TIME
Cumulative

Batch Coded Form D.T %F

% drug

Code
release

X1 X2 200
0
B1 -1 -1 41±1.02 0.98 0 10 20 %CPR T3
B2 -1 0 37±1.12 0.76
B3 -1 1 31±0.97 0.43 Time %CPR T7
B4 0 -1 29±0.87 1.02
B5 0 0 25±0.98 0.82
B6 0 1 21±0.78 0.51
B7 1 -1 30±0.89 0.98 Figure 4: Response surface plot for
B8 1 0 23±0.23 0.93 Disintegrating Time
B9 1 1 16±0.02 0.62
Check Point 0.33 -0.5 20.1 0.7
Actual Values
Coded
Values X1 (Croscarmelose
X2 (Kyron-T314)
sodium)
-1 2 3
0 3 4
1 4 5
Table 5: Result of Evaluation parameters of
tablets of factorial batches B1 to B9
Fact
Avg. Drug Wetting
orial Hardness Thickness
Wt. content time
Batc (kg/cm2) (mm)
(mg) (%)
Figure 5: Response surface plot for % Friability
hes
B1 3.7±0.13 2.97 ±0.7 148.5 98.2±0.34 39±1.13
B2 3.2±0.21 2.9±0.13 148.5 100.2±0.56 31±1.19
B3 3.0±0.09 3.0±0.12 149.4 97.1±0.12 27±0.92
B4 2.88±0.32 2.9±0.06 151.1 102.1±0.29 20±1.2
B5 3.1±0.24 2.9±0.02 149.8 101.3±0.17 9±1.23
B6 2.7±0.17 2.9±0.14 151.5 99.3±0.21 19±0.98
B7 3.2±0.27 2.9±0.06 148.4 97.4±0.07 23±1.34
B8 3.24±0.34 3.0±0.04 149.2 96.6±0.3 18±1.21
B9 2.87±0.14 3.0±0.07 150.3 98.2±0.9 16±0.98

50 Int J Res Med. 2013; 2(4);48-53 e ISSN:2320-2742 p ISSN: 2320-2734

 Fast orodispersible tablets of Naratriptan Hydrochloride
DISCUSSION
For the preparation of ODTs of naratriptan
hydrochloride, formulations were designed by
selecting appropriate ingredients in appropriate
concentrations and the concentrations of
superdisintegrants were optimized thereafter. The
batches T1-T11 were prepared to achieve an
optimized concentration of superdisintegrant and the
most efficacious one among the three
superdisintegrants incorporated to prepare ODTs as
shown by the Table-1. Among the formulations
containing SSG (T1-T4), T3 exhibited the lowest
wetting time, disintegration time and highest %
cumulative drug release as shown in Table-3. This
might be due to the reason that SSG swells in 3D.
Up to 5% of SSG decreased disintegrating time and
wetting time. Therefore, as the concentration of SSG
increases from 2% to 4%, wetting time,
disintegration time not extends beyond 1 minute and
also the increased in drug release is seen. Among the
formulations containing CCS (T5-T7), T7 exhibited
lowest dispersion time, disintegration time and
highest % cumulative drug release as revealed by
Table-3. The formulations containing kyron-T314
(T8-T11), T11 depicted lowest wetting time
disintegration time and highest % cumulative drug
release as shown in Table-3. Thus the optimized
concentrations of superdisintegrants were found to
be 4% SSG, 4% CCS and 4% kyron-T314. So, we
can conclude that among these three
superdisintegrants, CCS came out to be the most
efficacious superdisintegrant to prepare ODT of
naratriptan hydrochloride as indicated by Figures 4,
which exhibits the disentrigating time of optimized
concentration of each superdisintegrant. Figures 1
exhibit dissolution profiles of formulations T3, T7,
T11 respectively. For optimization of concentration
of CCS and kyron-T314 to be used, A 32 factorial
design was employed in the investigation. The
amount of superdisntegrating agent (croscarmellose
sodium, X1) and (kyron 314, X2) were chosen as
independent variables in a 32 full factorial design. A
statistical model incorporating interactive and
polygonal terms was used to evaluate the responses.
Y=b0+ b1X1+ b2X2+ b12X1X2+ b11X1X1+
b22X2X2. Where Y is the dependent variable, b0 is
the arithmetic mean response of the 9 runs, and b is
the estimated coefficient for the factor Xi. The main
effects (X1 and X2) represented the average result of
changing 1 factor at a time from its low to high
values. The interaction terms (X1, X2) showed how
the response changes when two factors are
simultaneously changed. The polynomial terms (X12
and X22) were included to investigate nonlinearity.
Multiple linear regression analysis was performed
using Sigma State 3.5 Demo version software to
51 Int J Res Med. 2013; 2(4);48-53
generate the statistical relationship between the
independent variables and responses. For graphical
representation of the influence of factors, the contour
plots were generated for all dependent variables
using Sigma Plot 12. The disintegrating time and %
friability for the nine batches (B1 to B9) showed a
wide variation (i.e., 16 to 41 sec and 0.43% to
1.02%, respectively time) in Table-3. The data
clearly indicate that the disintegrating time and %
friability values are strongly dependent on the
selected independent variables. The fitted equations
(full model) relating the responses disintegrating
time and % friability to the transformed factors are
shown in Table-6. The polynomial equations and
response surface plot for % friability (Figure 3 and
4) can be used to draw conclusions after considering
the magnitude of co-efficient17.
Table 7: Summary of results of Regression
Analysis
Coefficients D.T %F
b0 25.22 0.83
b1 -6.66 0.06
b2 -5.33 -0.23
b12 -1.02 0.01
b11 4.66 0.041
b22 -0.33 0.085
R2 0.9941 0.9933
In Table-7 the negative sign which gives synergistic
effect and positive sign give antagonistic effect for
disintegration time b1 and b2 posses negative sign
which gives positive effect on disintegration time
but b1 have greater value than b2 it means
crosscarmellose sodium is more responsible for
faster disintegration than kyron314 because
porous structure was responsible for faster water
uptake; hence it facilitates wicking action of
kyron314 and for percent friability b1 posses
positive sign and b2 posses negative sign i.e.
croscarmellose sodium increase the friability
because create porous structure in tablet but b2
posses negative i.e. addition of kyron314 will helps
to decrease in friability. For disintegrating time, as
shown in figure 2 the surface plot reveled that a
corresponding increase in the disintegrating time
was observed with increase in concentration of
croscarmellose sodium and kyron-T314. This may
be due to powerful disintegrating properties. For
percentage friability as shown in figure 3 the surface
plot reveled that a corresponding increased in the
percentage friability was observed with increase in
concentration of croscarmellose sodium because of
porous structure but the % Friability decreased when
the concentration on kyron-T314 was increase.
Check point batch (optimized batch) was prepared
shown in table-4 at X1= 0.33 level and X2= -0.5. The
percentage friability of check point batch found to be
0.7% and the disintegration time found to be 21 sec.
Table-7 indicates that the results are expected. Thus,
e ISSN:2320-2742 p ISSN: 2320-2734
 Fast orodispersible tablets of Naratriptan Hydrochloride

we can conclude that t he statistical model is REFERENCES

mathematically valid18-20. 1. Chang R, Guo X, Burnside B and Couch R: A
Table 8: Physical Characteristics of oral fast review of fast dissolving tablets. Phar m Tech
disintegrating tablet of optimised Batch B9 at North Am 2000; 12: 52-58.
Temperature (40°C±2°C / 75% RH±5%) 2. Bi Y, Sunada H, Yonezawa Y, Danjo K and
Parameters (Initial) (After 1 months at 40°C) Iida K: Preparation and evaluation of
compressed tablets rapidly disintegrating in the
Disintegrating Time 17±0.12 19±0.21
oral cavity. Chem Pharm Bull 1996; 44: 2121-
Wetting Time 13±0.15 15±0.19 2127.
Water absorption
97.20±0.02% 95±0.04% 3. Cady RK, Went JK and Kircher JR, “Treatment
ratio
Drug Content 98.20±1.01% 96.40±1.02%
of acute migraine with subceutanus
Table 9: Cumulative % drug release of Batch B9 sumatriptan”. JAMA, 1991, 205, 2831-2853.
at 40°C±2°C/75% RH±5% 4. Tripathi KD: Essential of Medical
Pharmacology, Jaypee Publisher Ltd, Sevent h
Cumulative Cumulative % drug release
Time
% drug release (Initial) (After 1 months at 40°C) Edition 2008.
5. Kanthleen Parfitt: Martindale- The
0 0 0
Complete Drug Reference, The Royal
1 40.18 38.12
Pharmaceutical Society, Pharmaceutical Press,
2 48.62 44.78 Thirty second Edition 1999.
3 61.94 59.57 6. Sarasija, S., V. Pandit and H.P. Joshi, 2007.
CONCLUSION Mouth dissolving tablets of Salbutamol
The use of superdisintegrating for preparation of fast sulphate. Indian J. Pharm. Sci., 69: 467- 469.
disintegrating is highly effective and commercially 7. Indian Pharmacopoeia, the Controller of
feasible. The superdisintegrating accelerate Publication Delhi, 1996, 2, 735.
disintegrating of tablets by virtue of their ability to 8. Lachman L, Liberman H and Kanig J, “The
absorb a large amount of water when exposed to an theory and practice of industrial pharmacy.”
aqueous environment. The disintegrating is reported Varghese Publishing Hous, 1987, 297
to have an effect on dissolution characteristics as 9. Lachman, L., A. Lieberman and J.L. Kinig,
well. Prepared fast disintegrating tablets dispersed in 1991. The Theory and Practice of Industrial
the mouth quickly and released the drug. Figure 3 Pharmacy,Varghese Publishing House,pp:67-68
shown the cumulative percentage of naratriptan 10. Khan S, Kataria P, Nakhat P and Yeole P,
hydrochloride released from formulated tablet with “Taste masking of ondansetron hydrochloride
different concentration of sodium starch glycolate, by polymer carrier system and formulation of
croscarmellose sodium and kyron-T314. It is clear rapid-disintegrating tablets.” AAPS
that the dissolution and disintegration of naratriptan Pharm.Sci.Tech, 2007, 8(2), 46.
hydrochloride improved considerably in batch T7 11. Morita Y, Tsushima Y, Yasui M, Termoz R,
containing crosscarmellose sodium (4%) as Ajioka J and Takayama K, “Evaluation of the
compared to the rest of formulation coating sodium disintegration time of rapidly disintegrating
starch glycolate and kyron-T314. Batch T7 tablet tablets via a novel method utilizing a CCD
showed good disintegrating efficiency (39 sec) and camera.” Chem. Pharm, 2002,50(9),1181-1186.
rapid dissolution in six minutes. The results of a 32 12. Ishikawa T, Kuizumi N, Mukai B, Utoguchi N,
full factorial design revealed that the amount of Fujii M, Matsumoto M, Endo H, Shirrotake S
croscarmellose sodium and kyron-T314 significantly and Watanabe Y, “Preparation of rapidly
affect the dependent variables, disintegration time, disintegrating tablet using new types of
and percentage friability. The B9 batch shows good microcrystalline cellulose (PH-M series) and L-
disintegrating properties (16sec) and high dissolution HPC by direct compression method.”Chem.
efficiency (in five minutes). It is thus concluded that Pharm. Bull, 2001, 9, 134-139.
by adopting a systematic formulation approach, an 13. Gohel M, Patel M, Amin A, Agrawal R, Dave R
optimum point can be reached in the shortest time and Bariya N, “Formulation design
with minimum efforts. Direct compressible andoptimization of mouth dissolve tablets of
technique would be an effective alternative approach nimesulide using vacuum drying
compared with the use of more expensive adjuvants technique.”AAPS PharmSciTech, 2004,5, 36.
in the formulation of ODT. There was no difference 14. Swamy, P.A., S.H. Areefulla, S.B. Shrisand, S.
observed in release profile and drug content after Gandra and B. Prashanth, 2007. Orodispersible
accelerated Stability study for 1 month. tablets of meloxicam using superdisintegrant
blends for improved efficiency. Ind. J. Pharm.
Sci., 69(6):836-840.
52 Int J Res Med. 2013; 2(4);48-53 e ISSN:2320-2742 p ISSN: 2320-2734
 Fast orodispersible tablets of Naratriptan Hydrochloride

15. Malke, S., S. Shidhaye and V.J. Kadam, 2007.
Formulation and evaluation of oxcarbazepine
fast dissolving tablets, Ind. J. Pharm. Sci, 69(2):
211-214.
16. Patel, M.M. and D.M. Patel, 2006. Fast
dissolving valdecoxib tablets containing solid
dispersion of valdecoxib, Ind. J. Pharm. Sci, 68
(2): 222-226.
17. Singh J, Singh R, Optimization and
formulation of orodispersible tablets of
meloxicam, Tropical J of Pharm Res 2009; 8(2):
153-159.
18. Parikh BN, Patel DM, Patel CN, Dave JB,
Gothi GD, Patel TD, Formulation optimization
and evaluation of immediate release tablet of
telmisartan, J of Global Pharm Tech 2010;2(2):
79-84.
19. Shid SL, Hiremath SP, Borkar SN, Sawant VA,
Shende VS, Tote MV, Birari R.B, Changrani
SR, effect of superdisintegrants in rapidly
disintegrating flurbiprofe n sodium
orodispersible tablets via direct compression and
camphor sublimation, J of Global Pharm Tech
2010; 2(1): 107-117.
20. Fujii M, Yamamoto Y, Kenichi W, Tsukamoto
M, Shibata Y, Kondoh M, Watanabe Y, Effect of
powder characteristics on oral tablet
disintegration, Int J Pharm 2009;365:116-120.

53 Int J Res Med. 2013; 2(4);48-53 e ISSN:2320-2742 p ISSN: 2320-2734